Tyco/Radionics Seeks Quality System Auditor Following FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Tyco Healthcare Group subsidiary Radionics should stop shipping certain products that FDA believes pose sterility concerns, the agency suggests in a warning letter dated March 8 and released March 26